About this trial
To Assess the pattern of renal injury in patients with inflammatory bowel disease and its relation to the duration and disease activity by Identification and characterization of early renal manifestations (e.g., proteinuria, hematuria, electrolyte imbalances) in IBD patients. and know Correlation between kidney involvement and IBD severity, including flare-ups and complications.
and know Impact of early renal manifestations on long-term renal outcomes, such as progression to CKD or development of AKI.
Eligibility criteria
Qualifiers
Adults aged 18 years or older
Confirmed diagnosis of IBD either crohns disease or ulcerative colities based on clinical ,endoscopic ,histological and radiological findings . - Patients in any stage of IBD, including remission, active disease, and flare-ups. - Willingness to participate and provide informed consent. - Renal Assessment for participants.
Disqualifiers
None
Trial design
Treatments tested in this trial
- Not listed